Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anhui Hualun Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical enterprise based in Anhui, China, specializing in the development and manufacturing of chemical drugs and traditional Chinese medicines. Founded in 1994, the company has established itself as a significant player in the production of large-volume parenteral infusions, small-volume injections, and various solid dosage forms. Its extensive product portfolio covers critical therapeutic areas including anti-infectives, cardiovascular diseases, and respiratory health. Hualun Pharmaceutical operates advanced, GMP-certified production lines that ensure high-quality standards for both domestic and international markets. The company is particularly recognized for its large-scale production of essential intravenous fluids and generic medications. Through continuous technical innovation, it remains a key contributor to the healthcare infrastructure in mainland China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hualun Pharmaceutical.